Cargando…
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Scientific advances over the last four decades have steadily infused the Alzheimer’s disease (AD) field with great optimism that therapies targeting Aβ, amyloid, tau, and innate immune activation states in the brain would provide disease modification. Unfortunately, this optimistic scenario has not...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885119/ https://www.ncbi.nlm.nih.gov/pubmed/35229269 http://dx.doi.org/10.1007/s13311-022-01201-2 |